9.3 Cardiogenic Shock, Cardiac Tamponade & Cardiac Arrest Resuscitation

9.3 Cardiogenic Shock, Cardiac Tamponade & Cardiac Arrest Resuscitation

[!NOTE] ANCC Blueprint Focus: Advanced resuscitation and hemodynamic stabilization in critical cardiovascular collapse form the core of Domain III (Evaluation and Modification) and Domain II (Planning and Implementation). Registered nurses must master invasive hemodynamic profiles, stage-based cardiogenic shock management, pericardiocentesis assistance, and high-fidelity ACLS execution.

Survival in catastrophic cardiovascular collapse hinges on prompt hemodynamic classification, rapid mechanical and pharmacologic unloading, and immediate execution of high-quality cardiopulmonary resuscitation.

Cardiogenic Shock: Definition, Hemodynamics & SCAI Classification

Cardiogenic Shock (CS) is a state of critical end-organ hypoperfusion and cellular hypoxia caused by primary cardiac pump dysfunction despite adequate or elevated intravascular volume.

Invasive Hemodynamic Diagnostic Criteria

Cardiogenic shock is confirmed by invasive pulmonary artery catheterization or clinical bedside criteria:

1. Persistent Systemic Hypotension: Systolic Blood Pressure $SBP < 90\text{ mmHg}$ or Mean Arterial Pressure $MAP < 65\text{ mmHg}$ for $>30\text{ minutes}$, or the continuous requirement for vasoactive infusions to sustain perfusion.
2. Severely Depressed Cardiac Index: $CI < 2.2\text{ L/min/m}^2$ (or $<1.8\text{ L/min/m}^2$ without pharmacologic/mechanical support).
3. Elevated Ventricular Filling Pressures: Pulmonary Artery Occlusion Pressure $PAOP > 15\text{ mmHg}$ (frequently $>18\text{ to }22\text{ mmHg}$) and Central Venous Pressure $CVP > 12\text{ mmHg}$.
4. Systemic Tissue Hypoperfusion Markers: Serum lactate $>2.0\text{ mmol/L}$, oliguria ($<0.5\text{ mL/kg/hr}$), cool, clammy extremities, delayed capillary refill, altered mental status, and low mixed venous oxygen saturation ($SvO_2 < 60\text{ to }65%$).

The SCAI Shock Classification (Stages A through E)

The Society for Cardiovascular Angiography and Interventions (SCAI) established a unified staging system to guide escalation of medical and mechanical therapies:

Pharmacotherapy & Mechanical Circulatory Support in Cardiogenic Shock

• Vasopressor Selection: Norepinephrine is the guideline-directed first-line vasopressor of choice. The landmark SOAP-II trial established that dopamine is associated with a significantly higher incidence of tachyarrhythmias and increased mortality in cardiogenic shock compared to norepinephrine. Norepinephrine restores coronary perfusion pressure via selective $\alpha_1$ vasoconstriction while providing modest $\beta_1$ inotropy without excessive tachycardia.
• Inotropic Support: Dobutamine (2.5 to 10 mcg/kg/min; $\beta_1$-dominant inotrope) or Milrinone (0.25 to 0.5 mcg/kg/min; PDE-3 inodilator). Milrinone is particularly effective in patients receiving chronic beta-blocker therapy and those with elevated pulmonary artery pressures, but requires dose reduction in renal dysfunction and may worsen hypotension.

                             [ TEMPORARY MCS MODALITIES ]
                                          │
         ┌────────────────────────────────┼────────────────────────────────┐
         ▼                                ▼                                ▼
   Intra-Aortic Balloon Pump           Impella Microaxial Flow Pump       Veno-Arterial ECMO
          (IABP)                                (Impella CP / 5.5)                 (VA-ECMO)
- Counterpulsation in aorta        - Microaxial pump across aortic valve - Full biventricular &
- Inflates in Diastole:               Draws blood from LV -> Aorta         pulmonary support
  Augments coronary perfusion      - Active LV Unloading (3.5-5.5 L/min) - Draws venous blood ->
- Deflates in Pre-Systole:         - Lowers PAOP, wall stress, and MVO2    Oxygenates -> Pumps into
  Reduces afterload & MVO2         - First-line for severe LV failure      femoral artery
- CONTRAINDICATIONS:               - CONTRAINDICATIONS:                  - Increases LV afterload
  Aortic Regurgitation,              Mechanical aortic valve, severe AR,   (requires venting with
  Aortic Dissection, severe PAD      LV thrombus                           Impella = 'ECPELLA')

Cardiac Tamponade: Pathophysiology, Beck's Triad & Pericardiocentesis

Cardiac tamponade is an acute, life-threatening condition in which fluid accumulation in the pericardial space elevates intrapericardial pressure to equal or exceed intracardiac chamber filling pressure. This impairs diastolic ventricular filling, reduces stroke volume, and precipitates severe low-output cardiogenic collapse.

Pathophysiological Cascade: Intrapericardial Pressure & Equalization

1. Loss of Pericardial Compliance: The normal pericardial sac contains 15 to 50 mL of lubricating serous fluid. When fluid accumulates rapidly (e.g., hemopericardium from cardiac rupture, trauma, aortic dissection, or post-catheterization wire perforation), as little as 150 to 200 mL exceeds the elastic limit of the fibrous pericardium, causing an exponential surge in intrapericardial pressure.
2. Equalization of Diastolic Pressures: As intrapericardial pressure rises, it compresses the thin-walled right atrium and right ventricle during diastole. Invasive hemodynamic monitoring reveals equalization of end-diastolic pressures throughout all four cardiac chambers ($RAP \approx RVEDP \approx PAD \approx PAOP$).
3. Impaired Stroke Volume: Compression prevents diastolic expansion, causing stroke volume and cardiac output to collapse.

Clinical Presentation: Beck's Triad & Pulsus Paradoxus

• Beck's Triad (The Classic Diagnostic Triad):
  1. Hypotension with a narrowing pulse pressure (due to severely depressed stroke volume).
  2. Jugular Venous Distension (JVD) with prominent neck veins and loss of the normal rapid $y$-descent (elevated central venous pressure with impaired right atrial emptying).
  3. Muffled / Distant Heart Sounds (due to the acoustic dampening effect of the pericardial fluid surrounding the heart).
• Pulsus Paradoxus: An exaggerated inspiratory drop in systolic blood pressure of $>10\text{ mmHg}$ during normal spontaneous breathing.
  • Mechanism (Ventricular Interdependence): During spontaneous inspiration, negative intrathoracic pressure pulls venous return into the right ventricle. In the rigidly constrained pericardial sac, the expanding right ventricle cannot bulge outward; instead, the interventricular septum bows leftward into the left ventricular cavity. This physically restricts left ventricular filling, causing an abrupt drop in LV stroke volume and systolic pressure during inspiration.
  • Measurement Technique: Inflate a manual sphygmomanometer cuff above systolic pressure. Deflate slowly at 2 mmHg/second. Note the pressure at which Korotkoff sounds are heard only during expiration. Continue deflating until sounds are heard during both inspiration and expiration. The numerical difference between these two points is the pulsus paradoxus value ($>10\text{ mmHg}$ is pathological).
• 12-Lead ECG Findings:
  • Sinus Tachycardia: The universal compensatory response to sustained low stroke volume ($CO = HR \times SV$).
  • Low QRS Voltage: Total QRS amplitude $<5\text{ mm}$ in all limb leads or $<10\text{ mm}$ in all precordial leads.
  • Electrical Alternans: Beat-to-beat alternating height, amplitude, and electrical axis of the QRS complex, produced by the physical swinging of the heart back and forth within the large fluid-filled pericardial sac.

Emergent Pericardiocentesis & Nursing Management

Emergency pericardiocentesis is the definitive treatment for cardiac tamponade with hemodynamic instability. Evacuating even 50 to 100 mL of fluid dramatically lowers intrapericardial pressure along the steep portion of the pericardial pressure-volume curve, immediately restoring stroke volume and arterial pressure.

• Subxiphoid Needle Insertion Approach:
  • Position patient at a 30- to 45-degree semi-Fowler's angle (allows fluid to pool dependently in the anterior-inferior pericardium).
  • Insert an 18-gauge spinal/pericardiocentesis needle between the xiphoid process and the left costal margin, angled 30 to 45 degrees toward the left shoulder under continuous bedside ultrasound guidance.
  • ECG Lead Monitoring: An alligator clip can be attached from the needle hub to lead $V_1$ of an ECG machine. If the needle contacts the epicardium, the monitor displays dramatic ST-segment elevation (injury pattern), indicating the needle must be slightly retracted.
• Supportive Resuscitation Pearls Prior to Drainage:
  • Administer an immediate intravenous crystalloid fluid bolus (500 to 1,000 mL normal saline) to expand intravascular volume and temporarily raise right atrial filling pressures above intrapericardial pressure.
  • AVOID positive pressure mechanical ventilation if possible. Positive intrathoracic pressure reduces venous return to the heart, exacerbates chamber compression, and triggers sudden, fatal cardiovascular collapse.

In-Hospital Cardiac Arrest (IHCA) & ACLS Resuscitation

High-quality cardiopulmonary resuscitation (CPR) and rapid defibrillation are the primary determinants of survival in adult cardiac arrest. Resuscitation follows the American Heart Association (AHA) Advanced Cardiovascular Life Support (ACLS) guidelines.

High-Quality CPR Performance Metrics

Shockable Rhythms: Ventricular Fibrillation (VF) & Pulseless VT (pVT)

1. Immediate Unsynchronized Defibrillation: Deliver a high-energy biphasic shock (120 to 200 Joules) as soon as the defibrillator is charged. Immediately resume chest compressions for 2 minutes before performing a rhythm or pulse check.
2. Vasopressor Therapy: Administer Epinephrine 1 mg IV/IO every 3 to 5 minutes, initiated after the second shockable rhythm check.
3. Antiarrhythmic Therapy: Administered for shock-refractory VF/pVT:
   • Amiodarone: First dose 300 mg IV/IO push, followed by a second dose of 150 mg IV/IO push if VF/pVT persists.
   • Lidocaine (Alternative): First dose 1.0 to 1.5 mg/kg IV/IO, followed by second doses of 0.5 to 0.75 mg/kg IV/IO (max cumulative dose 3 mg/kg).

Non-Shockable Rhythms: Asystole & Pulseless Electrical Activity (PEA)

In asystole and PEA, defibrillation is ineffective and harmful. Management centers on continuous high-quality CPR, early epinephrine, and identifying reversible underlying causes.

• Epinephrine Administration: Administer Epinephrine 1 mg IV/IO as early as possible in the resuscitation sequence, repeated every 3 to 5 minutes.

Reversible Causes: The H's and T's

During cardiac arrest resuscitation, the clinical team must systematically evaluate and treat the reversible causes of pulseless electrical activity and asystole: